Biogen lifts annual profit forecast as new treatments boost earnings

Go back to Biogen lifts annual profit forecast as new treatments boost earnings
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 214.02 -6.81 (3.08%)
Previous Close $220.83    52 Week High $333.65 
Open $215.45    52 Week Low $223.02 
Day High $217.28    P/E 27.40 
Day Low $210.54    EPS $7.81 
Volume 307,468